ATE414155T1 - Moraxella (branhamella) catarrhalis polypeptide - Google Patents
Moraxella (branhamella) catarrhalis polypeptideInfo
- Publication number
- ATE414155T1 ATE414155T1 AT02779066T AT02779066T ATE414155T1 AT E414155 T1 ATE414155 T1 AT E414155T1 AT 02779066 T AT02779066 T AT 02779066T AT 02779066 T AT02779066 T AT 02779066T AT E414155 T1 ATE414155 T1 AT E414155T1
- Authority
- AT
- Austria
- Prior art keywords
- branhamella
- moraxella
- polypeptides
- catarrhalis
- catarrhalis polypeptides
- Prior art date
Links
- 241000588621 Moraxella Species 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
- A61K39/1045—Moraxella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33144101P | 2001-11-16 | 2001-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE414155T1 true ATE414155T1 (de) | 2008-11-15 |
Family
ID=23293981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02779066T ATE414155T1 (de) | 2001-11-16 | 2002-11-15 | Moraxella (branhamella) catarrhalis polypeptide |
Country Status (9)
Country | Link |
---|---|
US (1) | US7410648B2 (de) |
EP (1) | EP1444349B1 (de) |
JP (2) | JP4413616B2 (de) |
AT (1) | ATE414155T1 (de) |
AU (1) | AU2002342466A1 (de) |
CA (1) | CA2464957A1 (de) |
DE (1) | DE60229871D1 (de) |
ES (1) | ES2316627T3 (de) |
WO (1) | WO2003043986A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018144383A1 (en) * | 2017-01-31 | 2018-08-09 | The Research Foundation For The State University Of New York | Vaccine against moraxella catarrhalis |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9810084D0 (en) | 1998-05-11 | 1998-07-08 | Cortecs Uk Ltd | Proteins |
GB9817824D0 (en) | 1998-08-14 | 1998-10-14 | Smithkline Beecham Biolog | Novel compounds |
US6673910B1 (en) | 1999-04-08 | 2004-01-06 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics |
WO2000071724A2 (en) | 1999-05-24 | 2000-11-30 | Smithkline Beecham Biologicals S.A. | Novel compounds from moraxella catarrhalis |
CA2378687A1 (en) | 1999-06-18 | 2000-12-28 | Elitra Pharmaceuticals, Inc. | Nucleotide sequences of moraxella catarrhalis genome |
AU8743001A (en) | 2000-08-28 | 2002-03-13 | Aventis Pasteur | Moraxella polypeptides and corresponding dna fragments and uses thereof |
GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
-
2002
- 2002-11-15 ES ES02779066T patent/ES2316627T3/es not_active Expired - Lifetime
- 2002-11-15 JP JP2003545623A patent/JP4413616B2/ja not_active Expired - Fee Related
- 2002-11-15 DE DE60229871T patent/DE60229871D1/de not_active Expired - Lifetime
- 2002-11-15 CA CA002464957A patent/CA2464957A1/en not_active Abandoned
- 2002-11-15 AU AU2002342466A patent/AU2002342466A1/en not_active Abandoned
- 2002-11-15 EP EP02779066A patent/EP1444349B1/de not_active Expired - Lifetime
- 2002-11-15 WO PCT/CA2002/001760 patent/WO2003043986A1/en active Application Filing
- 2002-11-15 US US10/495,643 patent/US7410648B2/en not_active Expired - Fee Related
- 2002-11-15 AT AT02779066T patent/ATE414155T1/de not_active IP Right Cessation
-
2009
- 2009-01-22 JP JP2009012033A patent/JP2009102394A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2005514011A (ja) | 2005-05-19 |
WO2003043986A8 (en) | 2003-08-28 |
JP2009102394A (ja) | 2009-05-14 |
WO2003043986A1 (en) | 2003-05-30 |
US20050070691A1 (en) | 2005-03-31 |
EP1444349A2 (de) | 2004-08-11 |
US7410648B2 (en) | 2008-08-12 |
JP4413616B2 (ja) | 2010-02-10 |
ES2316627T3 (es) | 2009-04-16 |
EP1444349B1 (de) | 2008-11-12 |
WO2003043986A3 (en) | 2003-11-27 |
AU2002342466A1 (en) | 2003-06-10 |
DE60229871D1 (de) | 2008-12-24 |
CA2464957A1 (en) | 2003-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE396199T1 (de) | Antimikrobielles polypeptid | |
DE60235761D1 (de) | Isoform des vegfs | |
ATE363531T1 (de) | Claudin polypeptide | |
MXPA03002971A (es) | Receptores de hematopoyetina hpr1 y hpr2. | |
DE69938935D1 (de) | Zyklische conotoxin-peptide | |
SE0203825D0 (sv) | Novel fused heterocycles and uses thereof | |
DE50206480D1 (de) | Antimikrobiell wirkendes peptid | |
DE60229871D1 (de) | Moraxella (branhamella) catarrhalis polypeptide | |
EA200000875A1 (ru) | Белки, взаимодействующие с каспазой-8 | |
DE60213365D1 (de) | Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen | |
DE60229845D1 (de) | Moraxella (branhamella) catarrhalis antigene | |
DK1276495T3 (da) | Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme | |
DE69921649D1 (de) | Moraxella catarrhalis pilq proteine | |
DE60230984D1 (de) | Moraxella (branhamella) catarrhalis antigene | |
ATE312922T1 (de) | Moraxella catarrhalis polynukleotide und polypeptide | |
DE50207389D1 (de) | Verwendung von lps zur behandlung intestinaler entzündungsprozesse | |
WO2003018052A8 (en) | Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments | |
ATE454452T1 (de) | Basb118 polypeptid und polynukleotid aus moraxella catarrhalis | |
DE60039303D1 (de) | Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen | |
ATE360073T1 (de) | Basb119 polypeptid und polynukleotid aus moraxella catarrhalis | |
ATE368686T1 (de) | Polypeptide aus moraxella (branhamella) catarrhalis | |
DE69919693D1 (de) | Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis | |
DE60019614D1 (de) | Moraxella catarrhalis antigen basb117 | |
ATE311458T1 (de) | Basb111 polypeptid und polynukleotid aus moraxella catharralis | |
ATE293692T1 (de) | Moraxella catarrhalis antigen basb120 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |